Sawai Group Holdings Reports Strong Profit Growth Amid Strategic Adjustments

An announcement from SAWAI GROUP HOLDINGS Co., Ltd. ( (JP:4887) ) is now available.

Sawai Group Holdings reported its consolidated financial results for the fiscal year ending March 31, 2025, revealing a significant increase in profit attributable to owners of the parent by 67.5% year-on-year, despite a decrease in total comprehensive income by 14.4%. The company also noted the classification of its U.S. business as a discontinued operation and executed a 3-for-1 stock split effective October 1, 2024, impacting earnings per share calculations. These strategic moves and financial outcomes reflect Sawai’s efforts to streamline operations and enhance shareholder value.

The most recent analyst rating on (JP:4887) stock is a Buy with a Yen2800.00 price target. To see the full list of analyst forecasts on SAWAI GROUP HOLDINGS Co., Ltd. stock, see the JP:4887 Stock Forecast page.

More about SAWAI GROUP HOLDINGS Co., Ltd.

Sawai Group Holdings Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily engaged in the pharmaceutical industry. The company focuses on the production and distribution of generic drugs, catering to a market that demands cost-effective healthcare solutions.

Average Trading Volume: 544,621

Technical Sentiment Signal: Buy

Current Market Cap: Yen195.9B

For a thorough assessment of 4887 stock, go to TipRanks’ Stock Analysis page.